A cute hepatocytic necrosis during use of ketoconazole for treatment of onychomycosis;Acute levercelnecrose bij gebruik van ketoconazol tijdens de behandeling van onychomycose

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 44, 1998, Pages 2416-2418

  Van Puijenbroek, E P ^a,b   Metselaar, H J ^a,c   Berghuis, P H E ^a,e   Zondervan, P E ^a,c,d   Stricker, B H Ch ^a,f  

^a Stichting Landelijke Registratie E   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Afd Maag Darm en Leverziekten ^*

^d ELKERLIEK HOSPITAL   (Netherlands)

^e Sectie Geneesmiddelenbewaking   (Netherlands)

^f ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; IMIDAZOLE DERIVATIVE; KETOCONAZOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG APPROVAL; DRUG USE; FEMALE; HUMAN; LIVER NECROSIS; MALE; NETHERLANDS; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTIFUNGAL AGENTS; FEMALE; HEPATITIS, TOXIC; HUMANS; INCIDENCE; KETOCONAZOLE; LIVER; MALE; MIDDLE AGED; NECROSIS; NETHERLANDS; ONYCHOMYCOSIS; SURVIVAL RATE;

EID: 0032585174     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Tester-Dalderup CBM. Ketoconazole. In: Dukes MNG, editor. Meyler's side effects of drugs. 13th ed. Amsterdam: Elsevier, 1996; 782-6.
2. Duarte PA, Chow CC, Simmons F, Ruskin J, Fatal hepatitis associated with ketoconazole therapy. Arch Intern Med 1984;144:1069-70.
3. Knight TE, Shikuma CY, Knight J. Ketoconazole-induced fulminant hepatitis necessitating liver transplantation. J Am Acad Dermatol 1991;25(2 Pt 2):398-400.
4. Lewis JH, Zimmerman HJ, Benson GD, Ishak KG. Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases. Gastroenterology 1984;86:503-13.
5. Bercoff E, Bernuau J, Degott C, Kalis B, Lemaire A, Tilly H. et al. Ketoconazole-induced fulminant hepatitis. Gut 1985;26:636-8.
6. Stricker BHCh. Drug-induced hepatic injury. Amsterdam: Elsevier, 1992;219-22.
7. Stricker BHCh, Blok APR, Bronkhorst FB, Parijs GE van, Desmet VJ Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases. J Hepatol 1986;3:399-406.
8. Lake-Bakaar G, Scheuer PJ, Sherlock S. Hepatic reactions associated with ketoconazole in the United Kingdom Br Med J (Clin Res Ed) 1987;294:419-22.
9. Svejgaard E, Ranek L. Hepatic dysfunction and ketoconazole therapy [letter]. Ann Intern Med 1982;96(6 Pt 1):788-9.
10. Chien RN, Yang LJ, Lin PY, Liaw YF. Hepatic injury during ketoconazole therapy in patients with onychomycosis: a controlled cohort study. Hepatology 1997;25:103-7.
11. Parijs GE van, Evenepoel C, Damme B van, Desmet VJ. Ketoconazole-induced hepatitis, a case with a definite cause-effect relationship. Liver 1987;7:27-30.
12. Bekkers GAH Toxische hepatitis door ketoconazol. Ned Tijdschr Geneeskd 1983;127:1114-5.
13. Kramer NJM, Montnor LP, Berghuis PHE. Toxische hepatitis tijdens gebruik van ketoconazol (Nizoral). Ned Tijdschr Geneeskd 1983;127:343-5.
14. Boetius G, Peeters JPC, Peters JH. Toxische hepatitis door ketoconazol (Nizoral) Ned Tijdschr Geneeskd 1983;127:341-3.
15. Offerhaus L, Het gele gevaar. Ned Tijdschr Geneeskd 1985;129: 1414-6.
16. Benson GD, Anderson PK, Combes B, Ishak KG. Prolonged jaundice following ketoconazole-induced hepatic injury. Dig Dis Sci 1988;33:240-6.
17. Garcia Rodrígues LA, Duque A, Castellsague J, Pérez Gutthann S, Stricker BHCh. A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. Pharmacoepidemiology and Drug Safety 1998:7(Suppl 2):167-8.